Please login to the form below

Not currently logged in
Email:
Password:

Good Relations to support launch of OTC drugs from infirst Healthcare

Follows five-way competitive pitch

Good Relations to support launch of OTC drugs from infirst HealthcareGood Relations Brand Communications has won its first account with infirst Healthcare, following a five-way competitive pitch.

The account, led by associate director, consumer health Kelly Blaney, will focus on the UK launch of two new over-the-counter (OTC) medicines. Six people will work on it and the work is expected to be complete – and the new medicines ready to be launched – within the next 12 months, Blaney told PMLiVE. 

The fully integrated go-to-market plans developed by the team include planning and creative development, web analysis and strategy development, medical marketing, experiential events and real-time 'Brand Newsrooms'.

“We were impressed with the way the client teams at Good Relations are formed into real-time 'Brand Newsrooms',” said infirst Healthcare chief executive officer Manfred Scheske, former president of GSK's European Consumer Healthcare business. 

“Teams drawn from corporate, consumer, healthcare and digital backgrounds, headed by a senior client lead, sit together to plan and implement flows of brand news through all channels which will maximise the opportunities for our brands,” he said. 

Good Relations is a multi-disciplined consultancy, providing creative communication solutions for consumer, b2b and corporate brands. The London-based company has a number of existing healthcare clients, including Oxford Fertility, Hammersmith Hospital and Intersystems. 

Infirst Healthcare, part of drug discovery expert Seek's portfolio, is a new consumer healthcare company working to improve well-established drugs with IP protected solutions for the OTC and primary care markets. It focuses on drugs which can be launched within 12 to 36 months.

25th September 2013

From: Sales, Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics